Search by Journal
- HOME
- > Search by Journal
- > Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Volume 27, Issue / 2017


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
On holding it for the 27th Japan circulation Japanese Pharmacological Society [theme] cardiovascular system innovative drug development innovation 今泉祐治 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 3-3, 2017. |
---|
![]() |
Inherited risk of the P-1 common arrhythmia "atrial fibrillation" 古川哲史 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 21-21, 2017. |
---|
![]() |
The new disease treatment strategy which paid its attention to S-1 mitochondria quality control 西田基宏1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 25-25, 2017. |
---|
![]() |
From S-2 identification - on tip analysis of the lumen pressure as the new neovascularisation inhibition signal 西山功一 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 26-26, 2017. |
---|
![]() |
Cardioprotection mechanism with the new network to tie S-3 heart, brain, kidney to 藤生克仁1), 真鍋一郎2), 小室一成1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 27-27, 2017. |
---|
![]() |
Elucidation of the cardiac homeostatic maintenance mechanism based on S-4 mRNA poly (A) chain control 久場敬司 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 28-28, 2017. |
---|
![]() |
Innovative drug development study for the LS-1 diabetic retinopathy 植村明嘉 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 31-31, 2017. |
---|
![]() |
The occurrence of A-01 multiplex stable myocardium avian guard activity: In association with the proarrhythmia 津元国親1), 倉田康孝2), 古谷和春3), 倉智嘉久1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 35-35, 2017. |
---|
![]() |
Development of the new heart failure therapeutic drug which assumed dimeric formation inhibition of A-02 myocardium-specific transcription factor GATA4 a target 清水聡史1), 依光奈津美1), 砂川陽一1),2),3), 船本雅文1),2), 刀坂泰史1),2),3), 宮崎雄介1),2),3), 和田啓道2), 長谷川浩二1),2), 森本達也1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 36-36, 2017. |
---|
![]() |
Chymase inhibition with the A-03 new nucleic acid preparation (aptamer) and cardiac activity improvement effect after myocardial infarction 金徳男1), 高井真司1), 野中洋介2), 山崎聡子2), 藤原将寿2), 中村義一2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 37-37, 2017. |
---|
![]() |
The transient ischemia conditioning of the A-04 remote organ inhibits the heart remodeling of the myocardial infarction chronic phase 山口雄大1), 泉康雄1),2), 塩田正之1),3), 北島正二朗1), 松永慎司1), 三浦克之5), 岩尾洋1),4), 冨田修平1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 38-38, 2017. |
---|
![]() |
A-05 Characterization of frequent-dependent changes of field potential duration in human induced pluripotent stem cell-derived cardiomyocytes sheets Hiroko Izumi-Nakaseko1), Yasunari Kanda2), Yuji Nakamura1), Mihoko Hagiwara-Nagasawa1), Takeshi Wada1),3), Kentaro Ando1), Atsuhiko T. Naito1), Yuko Sekino1),2),4), Atsushi Sugiyama1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 39-39, 2017. |
---|
![]() |
Search of RyR2 antagonist by the A-06 endoplasmic reticulum Ca2+ monitoring and the activated medicine 呉林なごみ1), 村山尚1), 田村真衣2), 哲翁直之1), 湯浅磨里2), 森修一2), 影近弘之2), 鈴木純二3),4), 金丸和典3),5), 飯野正光3),5), 櫻井隆1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 40-40, 2017. |
---|
![]() |
In a heart failure model mouse using the A-07 coarctation of the aorta technique, curcumin analog Y030 improved extension of the heart failure more strongly than curcumin 清水果奈1),2), 船本雅文1),2), 源平麻衣1), 砂川陽一1),2),3), 刀坂泰史1),2),3), 宮崎雄輔1),2),3), 柴田浩行4), 和田啓道2), 長谷川浩二1),2), 森本達也1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 41-41, 2017. |
---|
![]() |
Molecular mechanism of the expansion disorder due to the Ca2+ signal control rupture in A-08 cardiac muscle cells 三上義礼1), 伊藤雅方1), 杉本結衣1), 濱口正悟2), 冨田太一郎1), 村上慎吾1), 行方衣由紀2), 田中光2), 赤羽悟美1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 42-42, 2017. |
---|
![]() |
Analysis of the molecular mechanism to select an L-form Ca2+ channel current waveform in A-09 ventricle line action potential as 柏原俊英, 郭暁光, 中田勉, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 43-43, 2017. |
---|
![]() |
Examination about the difference between an individual, the clone of cardiac muscle cells derived from A-10 Japanese healthy adult iPS cells 内藤篤彦1),2), 伊藤正道3), 長澤(萩原)美帆子1), 中村裕二1), 後藤愛2), 千葉浩輝2), Nur Jaharat Lubna2), 中瀬古(泉)寛子1), 安東賢太郎1),2), 杉山篤1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 44-44, 2017. |
---|
![]() |
ET-1-induced constrictive developmental mechanism in the A-11 standstill type stellate cell of liver 鈴木良輔, 若林夢人, 西山良太, 山口桃生, 齊藤真也, 石川智久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 45-45, 2017. |
---|
![]() |
Examination of the cellular therapy for the anemia in renal disease using the erythropoietin producing cells which we differentiated from A-12 iPS cells and induced 人見浩史1),2), 中野大介1), 長船健二2), 西山成1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 46-46, 2017. |
---|
![]() |
In A-13 Dahl Salt Sensitive rat, the PDE5 inhibitor relieves a glomerulus disorder with the salt sensitive hypertension 冨田なつみ1), 堀田祐志1), 内木綾2), 片岡智哉3), 前田康博1), 高橋智2), 木村和哲1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 47-47, 2017. |
---|
![]() |
The ANP acts on vascular endothelial cells and proximal tubules cells in A-14 LPS instruction hotheadedness-related renal failure and shows an improvement effect 北村裕亮1), 中野大介2), 澤登慶治1), 西山成2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 48-48, 2017. |
---|
![]() |
The pharmacologic evaluation about the structural functional control structure of the coronary circulation in A-15 Microminipig: Comparison with the beagle 千葉浩輝2), 中瀬古(泉)寛子1), 内藤篤彦1),2), 高原章3), 中村裕二1), 後藤愛2), Nur Jaharat Lubna2), 長澤(萩原)美帆子1), 安東賢太郎1),2), 杉山篤1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 49-49, 2017. |
---|
![]() |
Vascular smooth muscle effect of B-01 solidification factor XI 平野勝也, 劉文華, 橋本剛, 山下哲生 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 53-53, 2017. |
---|
![]() |
Examination of the protective efficacy for the arteriosclerotic disease onset by the B-02 quercetin 石澤有紀1), 鍵本優有2), 今西正樹3), 堀ノ内裕也1), 鈴木琴子2), 岩田悠佑1),4), 座間味義人5), 武智研志6), 池田康将1), 玉置俊晃1), 石澤啓介3),5) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 54-54, 2017. |
---|
![]() |
About protection of iNOS in the rat vascular smooth muscle cell death by the B-03 extension stimulation 趙晶, 京谷陽司, 磯崎稔, 吉栖正典 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 55-55, 2017. |
---|
![]() |
Vascular responsiveness for the B-04 cGMP-producing medicine: Effect of a thiol oxidizer or the heme iron oxidizer 田和正志, 山下優香, 益岡尚由, 吉田純子, 西尾眞友, 石橋隆治 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 56-56, 2017. |
---|
![]() |
The adrenalin beta 2 receptor stimulation expands retinal blood vessels through the activation of the Gi protein -BKca channel course in B-05 rat 森麻美, 長谷川茉美, 谷合歩美, 坂本謙司, 中原努 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 57-57, 2017. |
---|
![]() |
Expression sthenia and PDGF signal of the Ca2+ in the B-06 pulmonary artery-related pulmonary hypertension-sensitive receptor 山村彩, 高橋理恵, Abdullah Al Mamun, 林寿来, 佐藤元彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 58-58, 2017. |
---|
![]() |
Functional analysis of the heart fibroblasts in the enlargement right ventricle of the B-07 lungs arterial hypertension model rat 井本圭亮, 岡田宗善, 山脇英之 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 59-59, 2017. |
---|
![]() |
Examination of the improvement effect of the pulmonary artery high blood pressure by the B-08 eicosapentaenoic acid 倉原琳1), 平石敬三1), 張影2), 山村彩3), 岸博子2), 小林誠2), 古賀佳織4), 鬼塚美樹4), 阿部弘太郎5), 塩井成留実6), 井上隆司1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 60-60, 2017. |
---|
![]() |
Three kinds of MAPK subfamilies regulate inflammation by different mechanism in B-09 human pulmonary microvessel endothelial cells 鈴木登紀子, Palikhe Sailesh, 坂田公正, 水野夏実, 服部裕一 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 61-61, 2017. |
---|
![]() |
Effect for the vessel walls constitution cells of the unsaturated carbonyl compounds included in the B-10 cigarette smoke gas phase 堀之内孝広1), 東恒仁1), 真崎雄一1), 三輪聡一1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 62-62, 2017. |
---|
![]() |
Mutual antagonism of B-11 adiponectin system and the oxidation LDL system 垣野明美1),2), 藤田佳子1),3), 堀内清香1), 沢村達也1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 63-63, 2017. |
---|
![]() |
The effect on blood vessel function of B-12 Poly (I:C): Mainly on an NO-dependent relaxation response 松本貴之, 安藤眞, 田口久美子, 小林恒雄 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 64-64, 2017. |
---|
![]() |
Etiological role of the exogenous NO generating system in B-13 metabolic syndrome, a vascular endothelium malfunction and the cardiovascular procedure death 筒井正人1), 喜名美香1),2), 坂梨まゆ子1), 松崎俊博1), 仲宗根淳子1), 新崎章2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 65-65, 2017. |
---|
![]() |
Effect for inflammation of levosimendan in the B-14 cecum ligation puncture-induced septicemic model mouse and milrinone of the heart and the function 山下重幸1),2), 鈴木登紀子1), 冨田賢吾1), 坂本卓也1), 酒井麻里1),2), 横尾宏毅3), 渡邊泰秀4), 芳村直樹2), 服部裕一1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 66-66, 2017. |
---|
![]() |
Mechanism of the mouse skeletal muscle differential inhibition with the B-15 sepsis factor lipopolysaccharide 大野雄康1), 黒川洵子2), 坂本多穗1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 67-67, 2017. |
---|
![]() |
Elucidation of the Ca2+ micro domain mechanism in cells controlling muscle tone of the B-16 vascular smooth muscle 佐伯尚紀1), 鈴木良明1), 山村寿男1), 竹島浩2), 今泉祐治1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 68-68, 2017. |
---|
![]() |
Analysis of molecular mechanism and the role of the vascular smooth muscle L-form Ca2+ channel activation with the YIA-1 platelet-derived growth factor 郭暁光, 柏原俊英, 中田勉, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 71-71, 2017. |
---|
![]() |
YIA-2 Were you able to predict increase in mortality due to Dronedarone in preclinical trials in the PALLAS trial? 長澤(萩原)美帆子1), 中村裕二1), 後藤愛2), 千葉浩輝2), Nur Jaharat Lubna2), 中瀬古(泉)寛子1), 安東賢太郎1),2), 内藤篤彦1),2), 杉山篤1),2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 72-72, 2017. |
---|
![]() |
YIA-3 ADAMTS1 promotes fibrosis with DOCA salt loading hypertensive rat kidney 鳥羽裕恵, 渡部裕介, Naseratun Nessa, 小原幸, 中田徹男 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 73-73, 2017. |
---|
![]() |
A spontaneous activity of the YIA-4 marmot pulmonary vein myocardium and role of the Na+ electric current ingredient in the diastolic depolarization 入江雅彦, 濱口正悟, 行方衣由紀, 田中光 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 74-74, 2017. |
---|
![]() |
Protective efficacy ... for new effect ... low activity bladder except the blood sugar control of the YIA-5 DPP-4 inhibitor anagliptin 堀田祐志1), 高橋瀬奈1), 所美里1), 内木綾2), 片岡智哉3), 前田康博1), 高橋智2), 木村和哲1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 27: 75-75, 2017. |
---|